|Dr. Emily Marine Leproust||Co-Founder, Pres, CEO & Director||524.67k||N/A||1973|
|Mr. James M. Thorburn||Chief Financial Officer||204.36k||N/A||1956|
|Mr. Mark Daniels Esq.||Sr. VP, Chief Legal Officer, Gen. Counsel, Chief Ethics & Compliance Officer and Sec.||489k||N/A||1963|
|Mr. William Charles Banyai||COO & Director||N/A||N/A||1955|
|Mr. Bill Peck||Chief Technology Officer||N/A||N/A||1960|
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. Twist Bioscience Corporation has a collaboration agreement with Pandion Therapeutics, Inc. to apply its antibody optimization platform for a targeting arm of a bispecific antibody. The company was founded in 2013 and is headquartered in San Francisco, California.
Twist Bioscience Corporation’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 8; Compensation: 8.